Afuco™ Anti-RSPO3 ADCC Recombinant Antibody (Rosmantuzumab), ADCC Enhanced (CAT#: AFC-TAB-449CQ)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to RSPO3. Rosmantuzumab is a humanized monoclonal antibody that can be potentially used in the treatment of Advanced Relapsed Tumor, Refractory Solid Tumors.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Normal Tissue
RNA Expression

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Humanized
  • Type
  • ADCC enhanced antibody
  • Specificity
  • Human RSPO3
  • Species Reactivity
  • Human
  • Clone
  • Rosmantuzumab
  • Applications
  • ELISA, IHC, FC, IP, IF, FuncS
  • Conjugate
  • Unconjugated
  • Generic Name
  • Rosmantuzumab
  • Related Disease
  • Advanced Relapsed Tumor, Refractory Solid Tumors

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • RSPO3; R-spondin 3; PWTSR; THSD2; CRISTIN1; R-spondin-3; R-spondin 3 homolog; roof plate-specific spondin-3; protein with TSP type-1 repeat; thrombospondin, type I, domain containing 2; thrombospondin type-1 domain-containing protein 2

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Rosmantuzumab"

Anti-Human RSPO3 Recombinant Antibody (Rosmantuzumab)
Recombinant monoclonal antibody to RSPO3. Rosmantuzumab is a humanized monoclonal antibody that can be potentially used in the treatment of Advanced Relapsed Tumor, Refractory Solid Tumors.

See other products for "RSPO3"

Single-domain Antibody

CAT Product Name Application Type
NAB-2146-VHH Recombinant Anti-Human RSPO3 VHH Single Domain Antibody IHC, IP, FC, Neut, FUNC Llama VHH

Humanized Antibody

CAT Product Name Application Type
TAB-351CT Humanized Anti-RSPO3 Recombinant Antibody (TAB-351CT) WB, ELISA, Neut, FC, IHC, IP Humanized IgG
TAB-351CT-S(P) Humanized Anti-RSPO3 Recombinant Antibody; scFv Fragment (TAB-351CT-S(P)) WB, ELISA, Neut, FC, IHC, IP Humanized scFv
TAB-351CT-F(E) Humanized Anti-RSPO3 Recombinant Antibody; Fab Fragment (TAB-351CT-F(E)) WB, ELISA, Neut, FC, IHC, IP Humanized Fab
TAB-449CQ Anti-Human RSPO3 Recombinant Antibody (Rosmantuzumab) ELISA, IHC, FC, IP, IF, FuncS IgG1, κ

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for AFC-TAB-449CQ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare